Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  10/14/2008
 
Trade Name:  Zomig Nasal Spray
 
Generic Name or Proper Name (*):  zolmitriptan
 
Indications Studied:  Migraine
 
Label Changes Summary:  Safety and effectiveness have not been established in pediatric patients less than18 years of age. A single, multi-center, double-blind randomized placebo-controlled study failed to demonstrate efficacy in pediatric patients ages 12 -17 years for the acute treatment of migraine headaches Adverse events similar to those observed in adults.
 
BPCA(B) and PREA(P):  B, P
 
Sponsor:  AstraZeneca
 
Pediatric Exclusivity Granted Date:  12/18/2003
 
NNPS:  FALSE'
 
Therapeutic Category:  Antimigraine
 
-
-